Overview
Registration
Covid 19 Statement
Faculty

Accreditation/
Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource®, LLC, and Pharmacy Times Continuing Education. Physicians’ Education Resource®, LLC, is accredited by the ACCME to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 24.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACPE

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 21.75 contact hours (2.175 CEUs) under the ACPE universal activity numbers:
0290-9999-19-196-L01-P
0290-9999-19-197-L01-P
0290-9999-19-198-L01-P

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 24.25 Contact Hours.

Acknowledgement of Commercial Support

This activity is supported by educational grants from AstraZeneca; BeyondSpring Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo, Inc.; Exelixis, Inc.; GlaxoSmithKline; Ipsen Biopharmaceuticals, Inc; Janssen Scientific Affairs, LLC and Pharmacyclics LLC, an AbbVie Company; ; Jazz Pharmaceuticals, Inc.; MacroGenics, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Seattle Genetics, Inc.; and Taiho Oncology, Inc.

38th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

38th Annual CFS®: Innovative Cancer Therapy for Tomorrow®


38th Annual CFS®

Virtual, Interactive Conference!

Wednesday, November 4, 2020 - 7:00 AM - 4:30 PM EST
Thursday, November 5, 2020 - 7:00 AM - 4:35 PM EST
Friday, November 6, 2020 - 7:00 AM - 4:30 PM EST

38th Annual Chemotherapy Foundation Symposium Overview

Exciting new breakthroughs and rapid changes continue to occur in the management of solid and hematologic malignancies. Just this past year, practice-changing diagnostic, therapeutic, and supportive care strategies have entered clinical practice, and many more are poised to enter the field. The application of optimized testing approaches, locoregional and systemic therapies, including the use of chemotherapies, targeted therapies, immunotherapies, alone and in combination, along with multimodal strategies, continue to drive improved outcomes across multiple lines of care. Critical knowledge, competence, and performance gaps among practitioners must be addressed to ensure that these approaches are effectively and safely integrated into professional practice.

Each year, the Chemotherapy Foundation Symposium® (CFS®), brings together more than 2000 healthcare professionals for 3 days, with the aim of promoting the delivery of evidence-based, state-of-the-art cancer care for both routine and the most challenging clinical scenarios. At the 38th Annual CFS®, our internationally renowned faculty will provide you with expert insights on the latest developments in cancer therapeutics, offering an unparalleled opportunity to learn how innovative approaches fit into existing treatment paradigms to optimize care and outcomes for your patients with cancer.

Benefits of Attending

  • Incorporate the latest clinical data and evidence-based strategies into your practice
  • Learn experts’ viewpoints on areas of clinical uncertainty
  • Network with the top minds in oncology
  • 100 Experts. 25 Tumor Types. 3 Days. 1 Meeting. Something for everyone!

Acknowledgement of Commercial Support

This activity is supported by educational grants from AstraZeneca; BeyondSpring Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo, Inc.; Exelixis, Inc.; GlaxoSmithKline; Ipsen Biopharmaceuticals, Inc; Janssen Scientific Affairs, LLC and Pharmacyclics LLC, an AbbVie Company; ; Jazz Pharmaceuticals, Inc.; MacroGenics, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Seattle Genetics, Inc.; and Taiho Oncology, Inc.

Target Audience

This educational activity is directed toward oncologists, hematologists, nurses, nurse practitioners, and pharmacists involved in the treatment/management of patients with cancer. Radiotherapists, immunologists, fellows, physician assistants, researchers, case managers, and other healthcare professionals interested in the treatment of cancer are also invited to attend.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Outline recent advances in biomarker testing across multiple tumor type for personalizing therapy
  • Discuss strategies to integrate recent evidence from clinical trials utilizing immunotherapy, targeted therapy, and/or chemotherapy across multiple tumor type into clinical practice
  • Review practice changing evidence presented at major conferences and that informs clinical decision making with respect to diagnosis or management across solid tumors as well hematologic cancers
  • Apply best practices and multidisciplinary strategies for monitoring, mitigating, and managing treatment-related toxicities in patients being treated for cancer

38th Annual Chemotherapy Foundation Symposium Co-Chairs

Benjamin Levy
Benjamin P. Levy, MD
Associate Professor, Johns Hopkins School of Medicine
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center
Sibley Memorial Hospital
Washington, DC
 
William K. Oh
William K. Oh, MD
Chief, Division of Hematology and Medical Oncology
Deputy Director, Tisch Cancer Institute
Professor of Medicine and Urology
Ezra M. Greenspan, MD, Professor in Clinical Cancer Therapeutics
Icahn School of Medicine at Mount Sinai
New York, NY
 
Tiffany A. Traina
Tiffany A. Traina, MD
Associate Attending Physician
Vice Chair, Oncology (Manhattan) Dept of Medicine
Clinical Director, Breast Medicine Service
Section Head, Triple Negative Breast Cancer Clinical Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medicine
New York, NY

38th Annual Chemotherapy Foundation Symposium Registration

Physicians' Education Resource
2 Clarke Drive, Suite 110
Cranbury, NJ 08512

Daily conference rates are now available!

We are pleased to offer flexible options to ensure viewers are able to participate in this valuable 3-day live, interactive conference. Don’t miss out on the chance to gain expert insights on cancer care from our renowned faculty.

To attend for one day only, use code CFS20Daily at checkout.

Registration Fees

  Virtual
Physicians $399
Fellows* $179
Nurses, PAs, Other Health Care Professionals $179
Industry** $675

Daily rates are now available, please call (877) 303-0104 for pricing.

*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount. Cannot be combined with other discounts/coupon codes.
**INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

A cancellation fee of 25% will be assessed on refunds requested prior to August 4, 2020, and a 50% fee on refunds requested on August 4, 2020 through September 4, 2020. No refunds will be made after September 4, 2020. There is no charge for substitution. Substitutions can be applied only to the same conference, and just 2 substitutions will be honored.

In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting continuing education materials.

Meeting information is accurate at the time of posting.




Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
  12345
6789101112
13141516171819
20212223242526
2728293031
Filter By